This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Americas GERD & NERD Treatment Market over the forecast period.
Pune, India -- (SBWIRE) -- 03/16/2018 -- MarketResearchFuture.com published a Cooked research report on "Americas GERD & NERD Treatment Market Research Report - Forecast to 2023" – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5554 .
The Americas GERD & NERD treatment market is expected to grow at the CAGR of 4.02% during the forecast period 2017-2023
The recent market developments has necessitated a 'see through' approach so as to avoid the slippery slope generated by the changing paradigms resulting from the powerful forces of economy, business models, competition and others. "Market Research future" presents its latest report titled "World GERD & NERD Treatment Market –forecast till 2023" to help clear the blur resulting from these developments and to give the reader a clear picture of the possibilities and nuisances lying ahead!
Considering the Americas GERD & NERD treatment market, there are two main regions: North America, and South America. North America consists of U.S. and Canada. The U.S. holds the largest market share due to the increasing burden of diseases, the share for gastric diseases is also increasing. The prevalence of acid reflux and related symptoms are increased across the globe by nearly 50% over the last decade.
Moreover, among all the geographical regions, North America has the highest GERD (gastroesophageal reflux disease) prevalence of 18.1%-27.8%. In North America, the U.S. has the highest prevalence of 26.2%.
According to the University of Michigan, more than 60 million American adults suffer from heartburn at least once a month and over 25 million experience heartburn daily. About 42% of the U.S. population experience heartburn at some point.
The American Cancer Society estimated that about 28,000 cases of stomach cancer are expected to diagnose and nearly 10,960 people may die from stomach cancer in 2017
According to the American Cancer Society, there were nearly 24,590 new cases of stomach cancer in 2015 and 10,720 deaths in the same year.
Major players in GERD & NERD treatment market:
Some of the major players in this market are AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co. Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), Sanofi (France).
Heartburn is the burning sensation in the chest behind the breastbone that we feel when stomach acid refluxes back into the esophagus (food tube). Increasing prevalence of gastric diseases has increased the investment in GERD medication for research and development. This is expected to further drive the demand for gastroenteric drugs.
The Americas GERD & NERD treatment market is growing continuously and is expected to grow at a CAGR of 4.02 % from 2017 to 2023.
ACCESS COMPLETE REPORT@ https://www.marketresearchfuture.com/reports/gerd-and-nerd-treatment-market-5554 .
Americas GERD & NERD treatment market is segmented on the basis of drug class, dosage form, and end user. On the basis of drug class, the market is segmented into antacids (acid neutralizers), proton pump inhibitors, H2 receptor blocker, prokinetic agents, antidepressants, calcium channel blockers, and others. Proton pump inhibitors are further segmented into esomeprazole, omeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, and others. H2 receptor blocker is further segmented into ranitidine, famotidine, cimetidine, nizatidine, and others. Prokinetic agents are further segmented into domperidone, metoclopramide, itopride, prucalopride, cisapride, benzamide, mosapride, erythromycin, and others. Based on the dosage form, it is segmented into solid and liquid. On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others.
MAJOR TABLE OF CONTENTS:
CHAPETR 1. REPORT PROLOGUE
CHAPETR 2. MARKET INTRODUCTION?
CHAPETR 3. RESEARCH METHODOLOGY
CHAPETR 4. MARKET DYNAMICS
CHAPETR 5. MARKET FACTOR ANALYSIS
CHAPETR 6. AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS
CHAPETR 7. AMERICAS GERD & NERD TREATMENT MARKET, BY DOSAGE FORM
CHAPETR 8. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER
CHAPETR 9. AMERICAS GERD & NERD TREATMENT MARKET, BY REGION
CHAPETR 10. COMPETITIVE LANDSCAPE
CHAPETR 11. COMPANY PROFILES
CHAPETR 12. APPENDIX
CHAPETR 13. MRFR CONCLUSION
AVAIL AMAZING DISCOUNT ON REPORT @ https://www.marketresearchfuture.com/check-discount/5554 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312